Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reury-Perng Perng

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Lung Cancer (Amsterdam, Netherlands)|January 9, 2007
A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinomaYuh-Min Chen, Chong-Jen Yu, Chih-Hsin Yang, et al.
American Journal of Clinical Oncology|April 24, 2013
The association between tumor epidermal growth factor receptor (EGFR) mutation and multiple primary malignancies in patients with adenocarcinoma of the lungsYung-Hung Luo, Hsiang-Ling Ho, Chun-Ming Tsai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 19, 2011
A phase II randomized trial of gefitinib alone or with tegafur/uracil treatment in patients with pulmonary adenocarcinoma who had failed previous chemotherapyYuh-Min Chen, Wen-Chien Fan, Chun-Ming Tsai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patientsGee-Chen Chang, Chun-Ming Tsai, Kun-Chieh Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
Cisplatin-based three drugs combination (NIP) as induction and adjuvant treatment in locally advanced non-small cell lung cancer: final resultsMaya Gottfried, Rodryg Ramlau, Maciej Krzakowski, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2010
Efficacy and safety of nemonoxacin versus levofloxacin for community-acquired pneumoniaDirkie J J van Rensburg, Reury-Perng Perng, Ismail H Mitha, et al.
Chest|August 13, 2011
IV delivery of induced pluripotent stem cells attenuates endotoxin-induced acute lung injury in miceKuang-Yao Yang, Hsin-Chin Shih, Chorng-Kuang How, et al.
Experimental and Therapeutic Medicine|September 13, 2012
Erlotinib has better efficacy than gefitinib in adenocarcinoma patients without EGFR-activating mutations, but similar efficacy in patients with EGFR-activating mutationsWen-Shuo Wu, Yuh-Min Chen, Chun-Ming Tsai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2010
Different efficacies of erlotinib and gefitinib in taiwanese patients with advanced non-small cell lung cancer: a retrospective multicenter studyWen-Chien Fan, Chong-Jen Yu, Chun-Ming Tsai, et al.
Japanese Journal of Clinical Oncology|December 5, 2006
Revisit of 1997 TNM staging system--survival analysis of 1112 lung cancer patients in TaiwanReury-Perng Perng, Chih-Yi Chen, Gee-Chen Chang, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Lung Cancer (Amsterdam, Netherlands)|January 9, 2007
A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinomaYuh-Min Chen, Chong-Jen Yu, Chih-Hsin Yang, et al.
American Journal of Clinical Oncology|April 24, 2013
The association between tumor epidermal growth factor receptor (EGFR) mutation and multiple primary malignancies in patients with adenocarcinoma of the lungsYung-Hung Luo, Hsiang-Ling Ho, Chun-Ming Tsai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 19, 2011
A phase II randomized trial of gefitinib alone or with tegafur/uracil treatment in patients with pulmonary adenocarcinoma who had failed previous chemotherapyYuh-Min Chen, Wen-Chien Fan, Chun-Ming Tsai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patientsGee-Chen Chang, Chun-Ming Tsai, Kun-Chieh Chen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
Cisplatin-based three drugs combination (NIP) as induction and adjuvant treatment in locally advanced non-small cell lung cancer: final resultsMaya Gottfried, Rodryg Ramlau, Maciej Krzakowski, et al.
Antimicrobial Agents and Chemotherapy|July 28, 2010
Efficacy and safety of nemonoxacin versus levofloxacin for community-acquired pneumoniaDirkie J J van Rensburg, Reury-Perng Perng, Ismail H Mitha, et al.
Chest|August 13, 2011
IV delivery of induced pluripotent stem cells attenuates endotoxin-induced acute lung injury in miceKuang-Yao Yang, Hsin-Chin Shih, Chorng-Kuang How, et al.
Experimental and Therapeutic Medicine|September 13, 2012
Erlotinib has better efficacy than gefitinib in adenocarcinoma patients without EGFR-activating mutations, but similar efficacy in patients with EGFR-activating mutationsWen-Shuo Wu, Yuh-Min Chen, Chun-Ming Tsai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2010
Different efficacies of erlotinib and gefitinib in taiwanese patients with advanced non-small cell lung cancer: a retrospective multicenter studyWen-Chien Fan, Chong-Jen Yu, Chun-Ming Tsai, et al.
Japanese Journal of Clinical Oncology|December 5, 2006
Revisit of 1997 TNM staging system--survival analysis of 1112 lung cancer patients in TaiwanReury-Perng Perng, Chih-Yi Chen, Gee-Chen Chang, et al.
Pageof 10